Early Detection Accelorator Grant
Funding Providers
Pankind
Location
Australia WideFunding Type
Cash grant G21492
Primary Category
ResearchEligible to
- Universities
- Businesses
- Not-for-Profits
- Individuals
Funding
Amount (max): $300,000Total pool: Undisclosed
Round(s)
- Opened 12-May-2026 Closes 14-Aug-2026
Purpose
Focused on advancing early detection approaches from research to clinical application for pancreatic cancer patients.
Overview
This Grant will provide funding to Australian researchers to
- Carry out developed projects that will significantly advance early detection methods toward clinical validation or implementation
- Contribute to the translation of early detection research from the laboratory to clinical studies or practice
- Accelerate the translation of promising detection strategies, including biomarker development, imaging tools, or risk stratification approaches, toward clinical application
- Contribute to innovative projects that require resources to advance critical milestones
- Extend previous or existing work in early detection, scaling up research toward broader clinical applicability
- Grow capacity in pancreatic cancer early detection research in Australia
- Improve survival from pancreatic cancer in line with our mission to triple survival by 2030
Eligibility
Criteria for funding
- Applications must demonstrate that the proposed work is past the proof-of-concept stage. Projects where the primary research question remains at hypothesis-generation or early feasibility, or where fundamental feasibility has not yet been established, are not suited to this grant category
- Projects at discovery or target identification stage are also not eligible for this category
- Where biomarker-based approaches are proposed, applicants should specify whether the biomarker has been identified and analytically characterised, and what clinical validation steps are planned within the grant term
- Applications should include a description of the competitive landscape, what existing detection approaches exist, how the proposed work is differentiated, and why the proposed stage of development represents the right point for accelerated investment
- Where the project builds on prior Pankind-funded work or other prior funding, applicants should clearly state what was achieved in that prior phase and why the next stage requires accelerator-level resourcing
- Projects focused on cancer prevention or supportive care, rather than early detection and diagnosis are not in the scope of this scheme
- Applicants must disclose any potential overlap with other current or pending research funding
- International collaborations are encouraged if the PI is located in Australia.
Applications / Guidelines
Application methods:
Online
Contact Details
- Phone: (02) 7207 6970
- Email: info@pankind.org.au
We take pride in ensuring our data is up to date and accurate, but you should not rely on our data alone. Please double-check important information on the funder's website before applying.